Italia -
italiano -
Ministero della Salute
a/v set for dialog, gambro, althin, fresenius
b.braun avitum ag - linee arterovenose a doppioago
Italia -
italiano -
Ministero della Salute
a/v set for althin system 1000
b.braun avitum ag - linee arterovenose a doppioago
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
femseven
theramex ireland limited - estradiolo - estradiolo
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
lecithinum
o.t.i. s.r.l. officine terapie innovative - altri prodotti terapeutici - altri prodotti terapeutici
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
biorganic lecithin 1200 gisand kapseln
gisand ag - lecithinum e soja - kapseln - lecithinum e soja 1.2 g, excipiens pro capsula. - als roborans - phytotherapeutika
Unione Europea -
italiano -
EMA (European Medicines Agency)
blincyto
amgen europe b.v. - blinatumomab - linfoma di leucemia linfoblastica a cellule precursori - agenti antineoplastici - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
tomudex
pfizer italia s.r.l. - raltitrexed - raltitrexed
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
glucosio baxter s.p.a.
baxter s.p.a. - altri additivi per soluzioni endovena - altri additivi per soluzioni endovena
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
glucosio baxter s.p.a.
baxter s.p.a. - altri additivi per soluzioni endovena - altri additivi per soluzioni endovena
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
naidif
aziende chimiche riunite angelini francesco acraf spa - altri ipnotici e sedativi - altri ipnotici e sedativi